Home/Pipeline/Bivalirudin RTU

Bivalirudin RTU

Anticoagulation (PCI)

LaunchedCommercialN/A

Key Facts

Indication
Anticoagulation (PCI)
Phase
Launched
Status
Commercial
Company

About Gland Pharma

Gland Pharma's mission is to be a leading global provider of high-quality, affordable injectable medicines. The company has achieved this through a combination of deep expertise in complex sterile manufacturing, strategic partnerships like the one with Fosun Pharma, and a successful IPO in 2020. Its core strategy focuses on expanding its CDMO business, leveraging its R&D for differentiated formulations, and penetrating new regulated and emerging markets to drive sustainable growth.

View full company profile